https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/kidney

The Latest

BLM health care

This Week in HIV Research: The Long Road to Racial Health Justice

Sept. 24, 2020: HIV adherence cohorts usually fail to reflect the diversity of the epidemic; HIV thrives in deprived neighborhoods; rethinking barriers to rapid HIV treatment initiation; long-term adverse events on INSTIs vs. efavirenz.

By Barbara Jungwirth and Myles Helfand
pile of prescription pill bottles

This Week in HIV Research: How Many Pills Can a Person Miss?

Nov. 20, 2019: Adherence required to maintain suppression; the accuracy of Framingham scores in assessing cardiovascular risk; long-term success rates for kidney transplants; integration of hypertension services with HIV care.

By Barbara Jungwirth and Myles Helfand
Timothy Ray Brown at the Association of Nurses in AIDS Care (ANAC) in Portland, Oregon

The Berlin Patient, the First Person Ever Cured of HIV, on Taking PrEP: "I Want a Full Sexual Life"

Timothy Ray Brown, known as "the Berlin patient," has begun taking PrEP to make sure he doesn't have to deal with an HIV diagnosis -- again.

By Sony Salzman
Prescription medicine bottles on lipid blood test report

This Week in HIV Research: Much Ado About Lipids

Oct. 17, 2019: Tesamorelin as treatment for non-alcoholic fatty liver disease; reversing lipid changes via TDF => TAF => TDF; statin use and reduced chronic kidney disease risk; statin use and (no) reduced HIV persistence.

By Barbara Jungwirth and Myles Helfand
people in a doctor's office waiting room

This Week in HIV Research: The Reality of Disparity

Sept. 26, 2019: Racial disparities in the PrEP continuum; HIV and ocular syphilis; Kaposi sarcoma among people with well-suppressed HIV; modifiable risk factors in the management of chronic kidney disease.

By Barbara Jungwirth and Myles Helfand
person rolling joint, focus on hands, cannabis on table

This Week in HIV Research: Sex, Drugs, and Broken Bones

Aug. 8, 2019: Casual sex partners increase among U.S. MSM; why some MSM undervalue PrEP; proteinuria prevalence and fracture risk; cannabis, cocaine, and inflammation in people living with HIV.

By Barbara Jungwirth and Myles Helfand
Syringe.

New Drug Approved for Complicated Urinary Tract and Intra-Abdominal Infections

The U.S. Food and Drug Administration has approved a three-drug regimen to treat complicated urinary tract infections and complicated intra-abdominal infections, both of which can be especially problematic for people living with HIV.

By Kenyon Farrow
Promo Image

This Week in HIV Research: The Science of Risk

Traditional factors vs. HIV-specific factors in non-communicable complications; frailty and fracture risk among women; lipid measurements and coronary risks; new data on efavirenz and birth defects.

By Barbara Jungwirth and Myles Helfand
Promo Image

This Week in HIV Research: Renal Upsides for Tenofovir Alafenamide

E/C/F/TAF viability for dialysis patients; TAF safety following renal damage; mental health needs for American Indians; parenting desires of people with HIV.

By Barbara Jungwirth and Myles Helfand
After Hepatitis C Cure, Kidney Problems Linked to Cocaine Use Img

After Hepatitis C Cure, Kidney Problems Linked to Cocaine Use

For people who used cocaine after being cured of HCV, the health of their kidneys declined at a relatively rapid pace.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange